Repurposed drug shows promise for treating COVID-19 inflammation

Yale clinicians report promising results after treating COVID-19 with the drug tocilizumab, which is known to reduce inflammation in chemotherapy patients.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news